CircUBE3A inhibited endothelium–mesenchymal transition by promoting UBE3A mRNA degradation via ac4C modification in diabetic vascular impairment
Biochemical Pharmacology · 2026-09 · 251 · 118091
DOI: 10.1016/j.bcp.2026.118091 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biochemical Pharmacology, 2026-09. Verfasst von Siyi Tang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, the Affiliated Hospital of Southwest Medical University and Key Laboratory of Medical Electrophysiology, Ministry of Educatio…. Hauptthemen laut MEDLINE: Endothelial-Mesenchymal Transition, RNA, Circular, Ubiquitin-Protein Ligases, RNA, Messenger. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: Sichuan Provincial Science and Technology Support Program, Science Fund for Distinguished Young Scholars of Hubei Province, Hubei Province Department of Science and Technology.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, the Affiliated Hospital of Southwest Medical University and Key Laboratory of Medical Electrophysiology, Ministry of Education, Institute of Cardiovascular Research and Institute of Metabolic Dis…
- Institute of Pharmaceutical Innovation, Department of Pharmacy, College of Medicine, Wuhan University of Science and Technology, Wuhan, Hubei Province, China.
- Department of Cardiology, the Affiliated Hospital of Southwest Medical University and Key Laboratory of Medical Electrophysiology, Ministry of Education, Institute of Cardiovascular Research and Institute of Metabolic D…
Förderung
- Sichuan Provincial Science and Technology Support Program
- Science Fund for Distinguished Young Scholars of Hubei Province
- Hubei Province Department of Science and Technology
- National Natural Science Foundation of China
Zitieren
APA
Tang, S., Zhou, W., Li, C., Zhang, C., Yang, K., He, S., & Yuan, Q. (2026). CircUBE3A inhibited endothelium–mesenchymal transition by promoting UBE3A mRNA degradation via ac4C modification in diabetic vascular impairment. Biochemical Pharmacology, 251, 118091. https://doi.org/10.1016/j.bcp.2026.118091
Vancouver
Tang S, Zhou W, Li C, Zhang C, Yang K, He S, et al. CircUBE3A inhibited endothelium–mesenchymal transition by promoting UBE3A mRNA degradation via ac4C modification in diabetic vascular impairment. Biochemical Pharmacology. 2026;251:118091. doi:10.1016/j.bcp.2026.118091
BibTeX
@article{Tang2026,
author = {Tang, Siyi and Zhou, Weiping and Li, Cheng and Zhang, Chao and Yang, Kai and He, Shuyi and Yuan, Qiong},
title = {CircUBE3A inhibited endothelium–mesenchymal transition by promoting UBE3A mRNA degradation via ac4C modification in diabetic vascular impairment},
journal = {Biochemical Pharmacology},
year = {2026},
volume = {251},
pages = {118091},
doi = {10.1016/j.bcp.2026.118091}
}
EUVIMED